Product NDC: | 0409-2347 |
Proprietary Name: | DOBUTamine Hydrochloride in Dextrose |
Non Proprietary Name: | DOBUTAMINE HYDROCHLORIDE |
Active Ingredient(s): | 200 mg/100mL & nbsp; DOBUTAMINE HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2347 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020201 |
Marketing Category: | NDA |
Start Marketing Date: | 20111011 |
Package NDC: | 0409-2347-33 |
Package Description: | 12 POUCH in 1 CASE (0409-2347-33) > 1 BAG in 1 POUCH > 250 mL in 1 BAG |
NDC Code | 0409-2347-33 |
Proprietary Name | DOBUTamine Hydrochloride in Dextrose |
Package Description | 12 POUCH in 1 CASE (0409-2347-33) > 1 BAG in 1 POUCH > 250 mL in 1 BAG |
Product NDC | 0409-2347 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DOBUTAMINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111011 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | DOBUTAMINE HYDROCHLORIDE |
Strength Number | 200 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |